Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by GREGORY N FULLER and ERIC JONASCH.
GREGORY N FULLER
Connection Strength
0.403
ERIC JONASCH
  1. Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial. Lancet Oncol. 2018 10; 19(10):1351-1359.
    View in: PubMed
    Score: 0.167
  2. HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas. Cancer Res. 2017 10 01; 77(19):5313-5326.
    View in: PubMed
    Score: 0.155
  3. Pilot study of dovitinib in patients with von Hippel-Lindau disease. Oncotarget. 2018 May 04; 9(34):23390-23395.
    View in: PubMed
    Score: 0.041
  4. Renal cell carcinoma brain metastasis with pseudoprogression and radiation necrosis on nivolumab after previous treatment with stereotactic radiosurgery: An illustrative case report and review of the literature. Pract Radiat Oncol. 2018 Sep - Oct; 8(5):e262-e265.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.